Outbreak caused by NDM-1- and RmtB-producing Escherichia coli in Bulgaria
Poirel, LaurentMedical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland - INSERM U914, South-Paris Medical School, K.-Bicêtre, France
Savov, EnchoLaboratory of Microbiology, Military Medical Academy, Sofia, Bulgaria
Nazli, ArzuMedical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland
Trifonova, AngelinaLaboratory of Microbiology, Military Medical Academy, Sofia, Bulgaria
Todorova, IvaLaboratory of Microbiology, Military Medical Academy, Sofia, Bulgaria
Gergova, IvankaLaboratory of Microbiology, Military Medical Academy, Sofia, Bulgaria
Nordmann, PatriceMedical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland - INSERM U914, South-Paris Medical School, K.-Bicêtre, France
Antimicrobial Agents and Chemotherapy. - 2014, vol. 58, no. 4, p. 2472–2474
English
Twelve consecutive carbapenem-resistant Escherichia coli isolates were recovered from patients (infection or colonization) hospitalized between March and September 2012 in different units at a hospital in Bulgaria. They all produced the carbapenemase NDM-1 and the extended-spectrum-β-lactamase CTX-M-15, together with the 16S rRNA methylase RmtB, conferring high-level resistance to all aminoglycosides. All those isolates were clonally related and belonged to the same sequence type, ST101. In addition to being the first to identify NDM-producing isolates in Bulgaria, this is the very first study reporting an outbreak of NDM-1-producing E. coli in the world.